Identification of Somatically Acquired <i>BRCA1/2</i> Mutations by cfDNA Analysis in Patients with Metastatic Breast CancerNeelima Vidula, Aditya Bardia, Michael S. Lawrence et al.|Clinical Cancer Research|2020Cited by 24
Characterization of TNG348: A Selective, Allosteric USP1 Inhibitor That Synergizes with PARP Inhibitors in Tumors with Homologous Recombination DeficiencyAntoine Simoneau, Scott Throner|Molecular Cancer Therapeutics|2025Cited by 17